ConductScience.org, home

Paper24978437

Androgen receptor expression in early triple-negative breast cancer: clinical significance and prognostic associations.

Pistelli M and 12 others. Cancers (Basel), 2014. Cited by 65 papers, by iCite.

Cite this record

ConductScience Library. Androgen receptor expression in early triple-negative breast cancer: clinical significance and prognostic associations. Papers, record 24978437. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24978437

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Androgen receptor expression in early triple-negative breast cancer: clinical significance and prognostic associations.
PubMed
Journal
Cancers (Basel)
PubMed
Year
2014
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
65
iCite
Relative citation ratio, by iCite
1.95
iCite
Revised in PubMed
2021-10-21
PubMed

Authors13

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Pistelli MMirco
2Caramanti MMiriam
3Biscotti TTommasina
4Santinelli AAlfredo
5Pagliacci AAlessandra
6De Lisa MMariagrazia
7Ballatore ZZelmira
8Ridolfi FFrancesca
9Maccaroni EElena
10Bracci RRaffaella
11Berardi RRossana
12Battelli NNicola
13Cascinu SStefano

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT04360941PAveMenT: Palbociclib and Avelumab in Metastatic AR+ Triple Negative Breast CancerBackground

Source ClinicalTrials.gov

Download CSV of trials

References44

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
121264529Prognostic value of androgen receptor expression in operable triple-negative breast cancer: a retrospective analysis based on a tissue microarray.Med Oncol2012https://conductscience.org/library/papers/21264529PubMed
212910513Androgen receptors frequently are expressed in breast carcinomas: potential relevance to new therapeutic strategies.Cancer2003https://conductscience.org/library/papers/12910513PubMed
310942095
Combined endocrine treatment of elderly postmenopausal patients with metastatic breast cancer. A randomized trial of tamoxifen vs. tamoxifen + aminoglutethimide and hydrocortisone and tamoxifen + fluoxymesterone in women above 65 years of age.
Breast Cancer Res Treat2000https://conductscience.org/library/papers/10942095PubMed
416538529
Randomized trial of tamoxifen alone or combined with fluoxymesterone as adjuvant therapy in postmenopausal women with resected estrogen receptor positive breast cancer. North Central Cancer Treatment Group Trial 89-30-52.
Breast Cancer Res Treat2006https://conductscience.org/library/papers/16538529PubMed
519638585Androgen receptor inhibits estrogen receptor-alpha activity and is prognostic in breast cancer.Cancer Res2009https://conductscience.org/library/papers/19638585PubMed
623965901Phase II trial of bicalutamide in patients with androgen receptor-positive, estrogen receptor-negative metastatic Breast Cancer.Clin Cancer Res2013https://conductscience.org/library/papers/23965901PubMed
722259247Expression of the androgen receptor and its correlation with molecular subtypes in 980 chinese breast cancer patients.Breast Cancer (Auckl)2012https://conductscience.org/library/papers/22259247PubMed
87748811Androgens induce divergent proliferative responses in human breast cancer cell lines.J Steroid Biochem Mol Biol1995https://conductscience.org/library/papers/7748811PubMed
921325075Androgen receptor expression and breast cancer survival in postmenopausal women.Clin Cancer Res2011https://conductscience.org/library/papers/21325075PubMed
10975004A demonstration of androgen and estrogen receptors in a human breast cancer using a new protamine sulfate assay.Cancer1976https://conductscience.org/library/papers/975004PubMed
119075695Androgen-induced inhibition of proliferation in human breast cancer MCF7 cells transfected with androgen receptor.Endocrinology1997https://conductscience.org/library/papers/9075695PubMed
1215897907Identification of molecular apocrine breast tumours by microarray analysis.Oncogene2005https://conductscience.org/library/papers/15897907PubMed
138911118The clinical significance of androgen receptors in breast cancer and their relation to histological and cell biological parameters.Eur J Cancer1996https://conductscience.org/library/papers/8911118PubMed
1410509795Androgen receptor agonist activity of the synthetic progestin, medroxyprogesterone acetate, in human breast cancer cells.Mol Cell Endocrinol1999https://conductscience.org/library/papers/10509795PubMed
1523031358Expression of androgen receptors in triple negative breast carcinomas.Acta Histochem2013https://conductscience.org/library/papers/23031358PubMed
167348567A prospective evaluation of chemohormonal therapy remission maintenance in advanced breast cancer.Breast Cancer Res Treat1981https://conductscience.org/library/papers/7348567PubMed
1710819508Role of the androgen receptor in human breast cancer.J Mammary Gland Biol Neoplasia1998https://conductscience.org/library/papers/10819508PubMed
188100853Immunohistochemical demonstration of androgen receptor in breast cancer and its relationship to other prognostic factors.J Pathol1993https://conductscience.org/library/papers/8100853PubMed
1918507821Androgen receptor expresion in breast cancer: relationship with clinicopathological characteristics of the tumors, prognosis, and expression of metalloproteases and their inhibitors.BMC Cancer2008https://conductscience.org/library/papers/18507821PubMed
2023929266Loss of androgen receptor expression predicts early recurrence in triple-negative and basal-like breast cancer.Mod Pathol2014https://conductscience.org/library/papers/23929266PubMed

See all 44 referencesDownload CSV of references

Cited by49

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 65 citations.

PMIDTitleJournalYearIn PapersSource
41948492Assessing the prognostic role of androgen receptor expression in non-metastatic triple-negative breast cancer.Front Oncol2026https://conductscience.org/library/papers/41948492PubMed
41723216EGFR and AR expression and co-expression in Indian triple-negative breast cancer with patient outcome association.Sci Rep2026https://conductscience.org/library/papers/41723216PubMed
41444310Decoding molecular signatures and identifying therapeutic targets in triple-negative breast cancer subtypes using omics and network analysis.Sci Rep2025https://conductscience.org/library/papers/41444310PubMed
40846987Clinical significance of androgen receptor in unilateral invasive breast cancer in women.Eur J Med Res2025https://conductscience.org/library/papers/40846987PubMed
40685652Androgen receptor expression in triple negative breast cancer: an Algerian population study.Libyan J Med2025https://conductscience.org/library/papers/40685652PubMed
40448099C/EBPβ increases tumor aggressiveness by enhancing KIFC1 expression in androgen receptor negative triple negative breast cancer.Cell Commun Signal2025https://conductscience.org/library/papers/40448099PubMed
40286049Androgen Receptors in Human Breast Cancer and Female Canine Mammary Tumors.Molecules2025https://conductscience.org/library/papers/40286049PubMed
40150035The Diagnostics of Disease Relapse Within Five-Year Follow-Up and the Role of Androgen Receptor Expression in Patients with Early Triple-Negative Breast Cancer.Diagnostics (Basel)2025https://conductscience.org/library/papers/40150035PubMed
39733399Effect of Androgen receptors in Triple-Negative Breast Cancer Given Neoadjuvant Therapy: A Systematic Review and Meta-Analysis.Asian Pac J Cancer Prev2024https://conductscience.org/library/papers/39733399PubMed
39062096Beyond Triple-Negative: High Prevalence of Quadruple-Negative Breast Cancer in African Americans.Biomedicines2024https://conductscience.org/library/papers/39062096PubMed
39020535Triple-negative breast cancer: from classical clinicopathological features to androgen receptor profile.Rom J Morphol Embryol2024https://conductscience.org/library/papers/39020535PubMed
38790919Frequency of Androgen Receptor Positivity in Tumors: A Study Evaluating More Than 18,000 Tumors.Biomedicines2024https://conductscience.org/library/papers/38790919PubMed
38741650Incidence and Prognostic Significance of Androgen Receptors (AR) in Indian Triple-Negative Breast Cancer (TNBC).Indian J Surg Oncol2024https://conductscience.org/library/papers/38741650PubMed
38555429The molecular subtyping and precision medicine in triple-negative breast cancer---based on Fudan TNBC classification.Cancer Cell Int2024https://conductscience.org/library/papers/38555429PubMed
37794999Does a 40% Cut-off Point for Ki-67 Expression Have a Role in Identifying the Development of Distant Metastasis Within 2 Years in Locally Advanced Triple Negative Breast Cancer Patients?Eur J Breast Health2023https://conductscience.org/library/papers/37794999PubMed
37553450Subcellular expression pattern and clinical significance of CBX2 and CBX7 in breast cancer subtypes.Med Mol Morphol2024https://conductscience.org/library/papers/37553450PubMed
37435469SAKK 21/12: a phase II trial of transdermal CR1447 in breast cancer patients.Endocr Oncol2022https://conductscience.org/library/papers/37435469PubMed
36232774AR Expression Correlates with Distinctive Clinicopathological and Genomic Features in Breast Cancer Regardless of ESR1 Expression Status.Int J Mol Sci2022https://conductscience.org/library/papers/36232774PubMed
36006309Hormonal Homologies between Canine Mammary Cancer and Human Breast Cancer in a Series of Cases.Vet Sci2022https://conductscience.org/library/papers/36006309PubMed
35203574Translational Implications of Dysregulated Pathways and microRNA Regulation in Quadruple-Negative Breast Cancer.Biomedicines2022https://conductscience.org/library/papers/35203574PubMed

See all 49 cited byDownload CSV of cited by

Genes8

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/24978437

GET https://conductscience.org/api/papers/v1/24978437/references?page=2